The previous page is sending you to https://www.businesswire.com/news/home/20240507085882/en/MiDROPS%C2%AE-Achieves-Pivotal-Milestone-Proven-Safe-and-Effective-in-Phase-II-Clinical-Trial.

 If you do not want to visit that page, you can return to the previous page.